Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Brazil

 

Will labour reform ignite the Brazilian homecare market?

Next on the reform agenda for Brazil’s centrist-Temer administration is the 70-year old labour code, 900 articles that menace businesses and are often blamed for 12% unemployment. The homecare industry, which relies on informal labour, could be a major benefactor predicts the CEO of the country’s largest formal chain.

Brazil’s new post-acute business model attracting foreign interest

The post-acute market presents a real opportunity in Brazil, after the ban against foreign investment in hospitals was lifted in 2015. This is according to Martin Benitez, an independent consultant with extensive M&A experience in the Brazilian healthcare market who is involved in just such a transaction. He speaks to Healthcare Nova about his latest project, and the market in general.

Hermes Pardini releases indicative pricing

The Brazilian lab group, Hermes Pardini, will sell 40.2m shares with an indicative pricing of BRL17.50 to BRL21.50. At the upper bound, the company is valued at BRL864.3m (US$274m).

Brazil’s Hermes Pardini to IPO

Brazil’s fourth largest diagnostics group Hermed Pardini has filed for an IPO, with proceeds expected to fund new acquisitions and greenfield projects – less than two months after competitor Alliar.

Spotlight on labs: India and Brazil

We look at labs in India, and profile the big lab and imaging groups in Brazil. Future articles will also look at the sector in China and across SE Asia and Africa.

Alliar breaks Brazil’s IPO drought

Brazil's third largest lab group Alliar floated on Friday 28 October at R$20 per share. This raises roughly US$88m in cash for its buy-and-build in southern Brazil. Investors celebrate the accomplishment as it puts an end to a yearlong IPO drought in Sao Paulo amidst recession.

How is healthcare investment in Brazil – after the foreign investment ban was lifted?

Brazil lifted the ban on foreign investments in hospitals in 2015. Is this attracting a new wave of healthcare investments and what is this doing to competition among the big groups? We ask independent consultant Martín Benítez Ramírez for an overview of the biggest deals. Ramirez has extensive M&A experience in Brazilian healthcare. He was in charge of […]

Find Us